Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.

Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant.

Dik WA, Zimmermann LJ, Naber BA, Janssen DJ, van Kaam AH, Versnel MA.

Pediatr Pulmonol. 2003 Jan;35(1):34-41.

PMID:
12461737
2.

Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity.

Currie AE, Kelly M, Vyas JR, Pandya H, Field D, Kotecha S.

Arch Dis Child Fetal Neonatal Ed. 2002 May;86(3):F193-7.

3.

The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants.

Kotecha S, Mildner RJ, Prince LR, Vyas JR, Currie AE, Lawson RA, Whyte MK.

Thorax. 2003 Nov;58(11):961-7.

4.

Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome.

Burón E, Garrote JA, Arranz E, Oyágüez P, Fernández Calvo JL, Blanco Quirós A.

Allergol Immunopathol (Madr). 1999 Jan-Feb;27(1):11-7.

PMID:
10217667
5.

Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity.

Dik WA, Versnel MA, Naber BA, Janssen DJ, van Kaam AH, Zimmermann LJ.

Eur Respir J. 2003 May;21(5):842-7.

6.

Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity.

Kotecha S, Silverman M, Shaw RJ, Klein N.

Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F143-7.

7.

Profiles of inflammatory cytokines in bronchoalveolar lavage fluid from premature infants with respiratory distress disease.

Huang HC, Yang MY, Huang CB, Yang KD.

J Microbiol Immunol Infect. 2000 Mar;33(1):19-24.

PMID:
10806959
8.

Concentration of nitric oxide products in bronchoalveolar fluid obtained from infants who develop chronic lung disease of prematurity.

Vyas JR, Currie AE, Shuker DE, Field DJ, Kotecha S.

Arch Dis Child Fetal Neonatal Ed. 1999 Nov;81(3):F217-20.

10.
11.

Ascorbate acid concentration in airways lining fluid from infants who develop chronic lung disease of prematurity.

Vyas JR, Currie A, Dunster C, Kelly FJ, Kotecha S.

Eur J Pediatr. 2001 Mar;160(3):177-84.

PMID:
11277380
12.

Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome.

Dik WA, van Kaam AH, Dekker T, Naber BA, Janssen DJ, Kroon AA, Zimmermann LJ, Versnel MA, Lutter R.

Biol Neonate. 2006;89(1):6-14. Epub 2005 Sep 8.

PMID:
16155381
13.

Cytokines in chronic lung disease of prematurity.

Kotecha S.

Eur J Pediatr. 1996 Aug;155 Suppl 2:S14-7. Review.

PMID:
8839740
14.
16.

Antithrombin III deficiency in neonatal respiratory distress syndrome.

Schmidt BK.

Blood Coagul Fibrinolysis. 1994 Jan;5 Suppl 1:S13-7; discussion S59-64. Review.

PMID:
8186352
17.

Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats.

Dik WA, McAnulty RJ, Versnel MA, Naber BA, Zimmermann LJ, Laurent GJ, Mutsaers SE.

Thorax. 2003 Sep;58(9):765-71.

18.

Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis.

Tani K, Yasuoka S, Ogushi F, Asada K, Fujisawa K, Ozaki T, Sano N, Ogura T.

Am J Respir Cell Mol Biol. 1991 Jul;5(1):34-40.

PMID:
1715176
19.

The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease.

Sweet DG, Curley AE, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, Warner JA.

Acta Paediatr. 2004 Jun;93(6):791-6.

PMID:
15244229
20.

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.

Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM.

J Rheumatol. 1995 Oct;22(10):1876-83.

PMID:
8991985

Supplemental Content

Support Center